Literature DB >> 8592593

Vascular reactivity during haemodialysis and isolated ultrafiltration: thermal influences.

W H van Kuijk1, A J Luik, P W de Leeuw, J P van Hooff, F H Nieman, H M Habets, K M Leunissen.   

Abstract

BACKGROUND: The present study was performed to assess the role of the extracorporeal blood temperature in the disparate cardiovascular response between isolated ultrafiltration and combined ultrafiltration-haemodialysis.
METHODS: In twelve stable dialysis patients (21-77 years), blood pressure and heart rate (Finapres) as well as forearm vascular resistance and venous tone (strain-gauge plethysmography) were measured during 1-h isolated ultrafiltration and 1-h combined ultrafiltration-haemodialysis (bicarbonate, sodium 141 mmol/l) at a fixed ultrafiltration rate of 0.91 l/h. The sequence of both treatment modalities was randomly defined within each patient. Serving as his or her own control, each patient was studied at two different dialysate temperatures: 37.5 and 35.0 degrees C.
RESULTS: At a dialysate temperature of 35.0 degrees C extracorporeal blood cooling during combined ultrafiltration-haemodialysis was comparable to isolated ultrafiltration. The cardiovascular response in isolated ultrafiltration was characterized by a significant increase in both forearm vascular resistance and venous tone, while heart rate even decreased. As a result, blood pressure remained unchanged or even increased. In contrast, during combined ultrafiltration-haemodialysis at a dialysate temperature of 37.5 degrees C the increase in forearm vascular resistance was only small and insignificant, while venous tone decreased significantly. Heart rate tended to increase. Combined ultrafiltration-haemodialysis at a dialysate temperature of 35.0 degrees C was also associated with a small increase in forearm vascular resistance. However, venous tone remained stable while heart rate decreased. At both dialysate temperatures, blood pressure was well maintained.
CONCLUSIONS: We conclude that differences in cardiovascular reactivity between isolated ultrafiltration and combined ultrafiltration-haemodialysis are only partially explained by differences in the extracorporeal blood temperature. In addition, especially venous reactivity is improved by lowering the dialysate temperature.

Entities:  

Mesh:

Year:  1995        PMID: 8592593

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

Review 1.  Intradialytic Hypotension: Mechanisms and Outcome.

Authors:  Benedict Sars; Frank M van der Sande; Jeroen P Kooman
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

Review 2.  Effect of Lowering the Dialysate Temperature in Chronic Hemodialysis: A Systematic Review and Meta-Analysis.

Authors:  Reem A Mustafa; Fadi Bdair; Elie A Akl; Amit X Garg; Heather Thiessen-Philbrook; Hassan Salameh; Sood Kisra; Gihad Nesrallah; Ahmad Al-Jaishi; Parth Patel; Payal Patel; Ahmad A Mustafa; Holger J Schünemann
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 8.237

3.  Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis.

Authors:  Charlotte Buchanan; Azharuddin Mohammed; Eleanor Cox; Katrin Köhler; Bernard Canaud; Maarten W Taal; Nicholas M Selby; Susan Francis; Chris W McIntyre
Journal:  J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 10.121

4.  Control of core temperature and blood pressure stability during hemodialysis.

Authors:  Frank M van der Sande; Grzegorz Wystrychowski; Jeroen P Kooman; Laura Rosales; Jochen Raimann; Peter Kotanko; Mary Carter; Christopher T Chan; Karel M L Leunissen; Nathan W Levin
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-08       Impact factor: 8.237

5.  Benefits of an early cooling phase in continuous renal replacement therapy for ICU patients.

Authors:  René Robert; Jean-Eudes Méhaud; Najette Timricht; Véronique Goudet; Olivier Mimoz; Bertrand Debaene
Journal:  Ann Intensive Care       Date:  2012-08-23       Impact factor: 6.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.